THEY are arguably the biggest medical breakthrough of recent times, helping Brits to shed the pounds with barely any effort ...
Kailera Therapeutics is taking a somewhat unusual step in its effort to bring a new weight-loss drug to market. One of its phase 3 studies of ribupatide will test the dual GLP-1/glucose-dependent ...
GLP-1S HAVE BEEN called “wonder drugs” for how they have revolutionized weight loss, and they’re being explored for their ...
For people with obesity or type 2 diabetes, glucagon-like peptide 1 (GLP-1) agonists (including Mounjaro, Wegovy, and Ozempic) have been labeled miracle drugs. But they aren’t miraculous for everyone.
Novo Nordisk is seeing brisk early demand for its new weight-loss pill as competition with ​U.S. rival Eli Lilly intensifies. Investors now want proof that fast-rising prescriptions can offset a ...